Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC

Costs of Totally Robotic versus Surgeon-Assisted Robotic Lung Resection

Robotic-assisted thoracoscopic surgery (RTS) is safe and effective for patients with
 early-stage non-small cell lung cancer (NSCLC). During RTS, division, dissection, and sealing
 of lung tissue, bronchi, and blood vessels can be performed using handheld staplers with
 assistance from a bedside surgeon (Surgeon-Assisted), or totally robotically with robotic
 staplers and energy devices by the console surgeon (Totally Robotic). Totally Robotic lung
 resection enables the operating surgeon to perform the case independently, but its
 implication on costs and patient outcomes remains unknown. There also is, however, a lack of
 prospective research evaluating the costs of the two methods for dissection and vessel
 sealing in RTS. This RCT aims to evaluate the costs and perioperative patient outcomes of
 Totally Robotic lung resection using the Vessel Sealer Extend energy device (for vessels
 7mm) and the SureForm robotic stapler (Intervention) versus Surgeon-Assisted robotic lung
 resection using the Signia stapler (Control) during RTS for NSCLC using the da Vinci system.